跳至主要内容
临床试验/NCT03500406
NCT03500406终止不适用

Penile Lengthening Pre-Penile Prosthesis Implantation

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年3月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
24
试验地点
2
主要终点
Length Assessment of Penile Prosthesis Implanted

研究概览

简要总结

This study is intended to utilize a novel, class I (ie. lowest risk, clinical studies not required) medical device to determine whether penile length can be increased in men prior to undergoing a penile prosthesis implantation procedure.

详细描述

Men with erectile dysfunction, unresponsive to conservative therapies, are recommended to undergo placement of an inflatable penile prosthesis (IPP); however, it is a common complaint post-operatively that their penis length is shorter than what it was previously.

Several attempts have been made by investigators to optimize penile length prior to placement of the penile prosthesis. Compared to other options, penile traction therapy (PTT) offers several potential advantages in that it is minimally-invasive, does not increase the morbidity of surgery, and has not been shown to result in any long-term side effects.

A new penile traction device (RestoreX® ) was created and funded through Mayo Ventures. Given the clinical issue of dissatisfaction with penile length post IPP, the potential role for PTT, and limited amount of data available, we sought to perform a clinical trial evaluating the effect of PTT on increasing the total length of prosthesis which can be inserted. We additionally sought to determine if PTT resulted in improved post-operative satisfaction on total penile length achieved.

To accomplish the study, a population of men from Mayo Clinic planning to undergo placement of an IPP will be enrolled and given the option to either join the control (no treatment) group or PTT group for 3 months prior to their procedure. Outcomes will be assessed prior to surgery and 3, 6, and 12 months post-procedure. Results are to be used with the intent to publish in a scientific journal.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Men undergoing placement of a penile prosthesis
  • •Must be the first time a penile prosthesis is implanted
  • •Undergoing implantation of a 3-piece inflatable penile prosthesis

排除标准

  • •Prior ischemic priapism
  • •Any prior penile prosthesis surgeries
  • •Any prior penile surgeries other than circumcision
  • •Undergoing malleable penile prosthesis or Ambicor device

研究组 & 干预措施

Group 1 - Control

Sham Comparator

No treatment will be administered and men will not have to delay their IPP procedure

干预措施: Control (Other)

Group 2 - PTT 3x daily x 3 months

Experimental

Men will utilize penile traction therapy for 30 minutes three times daily for the 3 months prior to placement of their IPP

干预措施: RestoreX (Device)

结局指标

主要结局

Length Assessment of Penile Prosthesis Implanted

时间窗: From baseline to 3 months

The primary objective is to assess the length of the penile prosthesis inserted into subjects following completion of RestoreX® traction therapy compared to the control group (no treatment)

次要结局

  • Participant Compliance(From baseline to 3 months)
  • Participant Satisfaction With Traction(From baseline to 3 months)
  • Adverse Events With Use of Traction(From baseline to 3 months)
  • Operative Complications(3, 6, 12 months post-operative)
  • Stretched Penile Length(From baseline to 12 months)
  • Participant Satisfaction Penile Length(Baseline to 12 months post-operative)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Landon W. Trost

Consultant

Mayo Clinic

研究点 (2)

Loading locations...

相似试验